2026 NPPES data Pulmonary Disease Physician NPI 1124226899 M.D.
Verify on CMS →

Rina Awan, M.D.

Pulmonary Disease Physician in Houston, Texas. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 348 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
55%
generic claims · 45% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$439.68
30 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Rina Awan, M.D. filed 3,634 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in Houston, Texas, prescribing 55% generic.

4K
Part D claims, 2023
55%
generic prescribing
$439.68
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Rina Awan, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

3,634 Top 9% higher than 91% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2K+: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Rina Awan, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Rina Awan, M.D.?

Quality data not reported

NPI registry status

Active

Issued 07/04/2007

NPI 1124226899

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

3,634 149% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

Specialty distribution in Texas

How Pulmonary Disease Physician compares to other specialties among Texas providers

Texas providers

Largest specialties in Texas (% of in-state providers)

Behavior Technician - 5.6%Behavior Technician5.6%Student in an Organized Health Care Education/Training Program - 5.1%Student in an Organized Health Care Education/Training Program5.1%Family Nurse Practitioner - 4.5%Family Nurse Practitioner4.5%Professional Counselor - 4.4%Professional Counselor4.4%Pharmacist - 4.4%Pharmacist4.4%Speech-Language Pathologist - 3.9%Speech-Language Pathologist3.9%Pulmonary Disease Physician - 0.1%Pulmonary Disease Physician0.1%
Largest specialties in Texas (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Rina Awan, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 12000 RICHMOND AVE STE 355, Houston, TX, 77082, with a listed phone of (832) 776-1621. NPI 1124226899 was issued on 07/04/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Awan most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,634 prescription claims written by this provider, covering 348 Medicare beneficiaries and totaling roughly $1.7 million in drug spend, split 45% brand-name and 55% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12000 RICHMOND AVE STE 355
Houston, TX 77082

Provider Details

NPI 1124226899
Specialty Pulmonary Disease Physician
Credentials M.D.
Gender Female
NPI Issued 07/04/2007

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Rina Awan, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$440

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Rina Awan, M.D.. To verify Rina Awan, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Rina Awan, M.D. - brand share 45.0%
Pulmonary Disease Physician average

45% brand-name claims vs 55% generic, on 3,634 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,634
Total Claims
$1.7M
Total Drug Cost
348
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,735
Total Day Supply
133,765
Brand vs Generic
45% brand / 55% generic
Brand Drug Cost
$1.6M
Generic Drug Cost
$94K
Antibiotic Claims
252

Patient Demographics

Average Patient Age
71.9 years
Avg HCC Risk Score
2.36
Gender Split
62% female / 38% male
Age Distribution
<65: 48, 65-74: 160, 75-84: 110, 85+: 30

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Rina Awan, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Montelukast Sodium
571
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
567
Albuterol Sulfate Hfa
Albuterol Sulfate
289
Azithromycin
216
Pantoprazole Sodium
146
Fluticasone Propionate
142
Spiriva Respimat
Tiotropium Bromide
129
Anoro Ellipta
Umeclidinium Brm/Vilanterol Tr
125
Symbicort
Budesonide/Formoterol Fumarate
109
Combivent Respimat
Ipratropium/Albuterol Sulfate
100

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How Rina Awan, M.D. fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

Rina Awan, M.D.'s 3,634 claims are above the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Awan.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Rina Awan, M.D.'s specialty?
Rina Awan, M.D. specializes in Pulmonary Disease Physician and practices in Houston, Texas. Credentials: M.D..
How much does Rina Awan, M.D. prescribe under Medicare Part D?
In 2023, Rina Awan, M.D. wrote 3,634 Medicare Part D claims totaling $1.7M in drug costs for 348 beneficiaries.
Where is Rina Awan, M.D. located?
Rina Awan, M.D. is located at 12000 RICHMOND AVE STE 355, Houston, TX, 77082. Phone: (832) 776-1621.
What is Rina Awan, M.D.'s NPI number?
Rina Awan, M.D.'s National Provider Identifier (NPI) is 1124226899, issued on 07/04/2007.
Does Rina Awan, M.D. prescribe more brand-name or generic drugs?
Rina Awan, M.D.'s prescribing is 45% brand-name and 55% generic drugs by claim count, with $1.6M in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does Rina Awan, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Rina Awan, M.D.'s most frequently prescribed drugs include Montelukast Sodium, Trelegy Ellipta, Albuterol Sulfate Hfa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Rina Awan, M.D. accept Medicare?
Rina Awan, M.D. appears in CMS Medicare data with 3,634 Part D claims and 348 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Rina Awan, M.D.'s credentials?
Rina Awan, M.D.'s NPI is 1124226899 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.